COAG position history
The shares of Hemab Therapeutics (COAG) that SOROS FUND MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 25,000 shares, $918K, 0.01% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|